Tempo reale stimato
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
6,91 USD | +10,03% |
|
+0,88% | -17,57% |
09/05 | IGM BIOSCIENCES, INC. : RBC Capital Markets rimane Buy | ZM |
08/05 | IGM Biosciences, Inc. fornisce una previsione di fatturato per il secondo trimestre e l'intero anno 2024 | CI |
Attività
Numero di dipendenti: 216
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Engineered Immunoglobulin M Antibodies
100,0
%
| 1 | 100,0 % | 2 | 100,0 % | +99,25% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 1 | 100,0 % | 2 | 100,0 % | +99,25% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Fred Schwarzer
CEO | Chief Executive Officer | 72 | 01/02/03 |
Misbah Tahir
DFI | Director of Finance/CFO | 49 | 01/01/19 |
T. S. Harigopal
COO | Chief Operating Officer | - | 01/01/21 |
Chris Takimoto
CTO | Chief Tech/Sci/R&D Officer | 65 | 29/07/21 |
Bruce Keyt
CTO | Chief Tech/Sci/R&D Officer | 71 | 01/01/10 |
Lisa Wax
LAW | General Counsel | - | 01/01/21 |
Corporate Officer/Principal | - | 01/01/18 | |
George Gauthier
PRN | Corporate Officer/Principal | 52 | 12/04/21 |
Steven Weber
AUD | Comptroller/Controller/Auditor | 48 | 01/03/22 |
Paul Graffagnino
LAW | General Counsel | - | 01/01/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Felix Baker
BRD | Director/Board Member | 55 | 26/01/21 |
M. Wilsey
BRD | Director/Board Member | 71 | 31/01/19 |
Fred Schwarzer
CEO | Chief Executive Officer | 72 | 01/02/03 |
Michael Lee
BRD | Director/Board Member | 45 | 01/07/19 |
Julie Hambleton
BRD | Director/Board Member | 66 | 15/08/18 |
Director/Board Member | 55 | 01/08/18 | |
Director/Board Member | 43 | 01/08/18 | |
William Strohl
BRD | Director/Board Member | 71 | 01/08/18 |
Director/Board Member | 49 | 03/10/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 0 | 25 386 983 | 0 | 0 | 37,37 % |
Azione B | 1 | 33 636 592 | 22 059 861 ( 65,58 %) | 0 |
Coordinate società
IGM Biosciences, Inc.
325 East Middlefield Road
94043, Mountain View
+650 965 7873
http://www.igmbio.com![Indirizzo IGM Biosciences, Inc.(IGMS)](https://cdn.zonebourse.com/static/address/65338650.png)
Settore
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-17,57% | 371 Mln | |
+18,44% | 122 Mrd | |
+19,69% | 112 Mrd | |
-23,92% | 19,33 Mrd | |
-18,45% | 16,17 Mrd | |
-18,89% | 15,6 Mrd | |
-49,33% | 14,65 Mrd | |
+57,50% | 14,34 Mrd | |
+7,29% | 14 Mrd | |
+126,94% | 11,29 Mrd |
- Borsa valori
- Azioni
- Azione IGMS
- Società IGM Biosciences, Inc.